Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex

Condition:   Multiple SclerosisInterventions:   Drug: BIIB033;   Other: Placebo;   Drug: Interferon Beta-1aSponsor:   Biogen IdecActive, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials